Cargando…
Neuromuscular Weakness and Paralysis Produced by Snakebite Envenoming: Mechanisms and Proposed Standards for Clinical Assessment
Respiratory and airway-protective muscle weakness caused by the blockade of neuromuscular transmission is a major cause of early mortality from snakebite envenoming (SBE). Once weakness is manifest, antivenom appears to be of limited effectiveness in improving neuromuscular function. Herein, we revi...
Autores principales: | Bickler, Philip E., Abouyannis, Michael, Bhalla, Ashish, Lewin, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861841/ https://www.ncbi.nlm.nih.gov/pubmed/36668869 http://dx.doi.org/10.3390/toxins15010049 |
Ejemplares similares
-
Clinical management of snakebite envenoming: Future perspectives
por: Hamza, Muhammad, et al.
Publicado: (2021) -
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
por: Lewin, Matthew R., et al.
Publicado: (2022) -
Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018) -
Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation
por: Lewin, Matthew R, et al.
Publicado: (2013) -
Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming
por: Silva, Anjana, et al.
Publicado: (2017)